Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: A case report

Retrovirology

Volumn 5, Issue , 2008, Pages

  Quan, Yudong ^a   Brenner, Bluma G ^a   Dascal, André ^a   Wainberg, Mark A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FRAMESHIFT MUTATION; GENE DELETION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NONSENSE MUTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; VIRUS GENOME; VIRUS REPLICATION; ANTIVIRAL RESISTANCE; CLASSIFICATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PLASMA; PROVIRUS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; FRAMESHIFT MUTATION; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MUTATION, MISSENSE; PLASMA; POLYMORPHISM, GENETIC; PROVIRUSES; SELECTION (GENETICS); SEQUENCE DELETION;

EID: 45549099339     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-43     Document Type: Article

References (21)

1. Yamaguchi Y Gojobori T Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts Proc Natl Acad Sci U S A 1997, 94(4):1264-1269. 19779 9037041 10.1073/ pnas.94.4.1264
2. Zhang L Diaz RS Ho DD Mosley JW Busch MP Mayer A Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo J Virol 1997, 71(3):2555-2561. 191373 9032400
3. Domingo E Menendez-Arias L Holland JJ RNA virus fitness Rev Med Virol 1997, 7(2):87-96. 10.1002/ (SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0 10398474
4. Goodenow M Huet T Saurin W Kwok S Sninsky J Wain-Hobson S HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions J Acquir Immune Defic Syndr 1989, 2(4):344-352. 2754611
5. Wolinsky SM Korber BT Neumann AU Daniels M Kunstman KJ Whetsell AJ Furtado MR Cao Y Ho DD Safrit JT Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection Science 1996, 272(5261):537-542. 10.1126/science.272.5261.537 8614801
6. Vignuzzi M Stone JK Arnold JJ Cameron CE Andino R Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population Nature 2006, 439(7074):344-348. 1569948 16327776 10.1038/ nature04388
7. Lemey P Rambaut A Pybus OG HIV evolutionary dynamics within and among hosts AIDS Rev 2006, 8(3):125-140. 17078483
8. Tebit DM Nankya I Arts EJ Gao Y HIV diversity, recombination and disease progression: How does fitness "fit" into the puzzle? AIDS Rev 2007. 9(2):75-87. 17694675
9. Liner KJ 2nd Hall CD Robertson KR Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease J Neurovirol 2007, 13(4):291-304. 10.1080/13550280701422383 17849313
10. Stingele K Haas J Zimmermann T Stingele R Hubsch-Muller C Freitag M Storch-Hagenlocher B Hartmann M Wildemann B Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy Neurology 2001, 56(3):355-361. 11171901
11. Palmer S Kearney M Maldarelli F Halvas EK Bixby CJ Bazmi H Rock D Falloon J Davey RT Jr. Dewar RL Metcalf JA Hammer S Mellors JW Coffin JM Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis J Clin Microbiol 2005, 43(1):406-413. 540111 15635002 10.1128/JCM.43.1.406-413.2005
12. Tamura K Dudley J Nei M Kumar S MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0 Mol Biol Evol 2007, 24(8):1596-1599. 10.1093/molbev/msm092 17488738
13. Ntemgwa M Wainberg MA Oliveira M Moisi D Lalonde R Micheli V Brenner BG Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine Antimicrob Agents Chemother 2007, 51(11):3861-3869. 2151428 17724152 10.1128/AAC.00646-07
14. Sanchez G Xu X Chermann JC Hirsch I Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals J Virol 1997, 71(3):2233-2240. 191331 9032358
15. Tominaga K Kato S Negishi M Takano T A high frequency of defective vif genes in peripheral blood mononuclear cells from HIV type 1-infected individuals AIDS Res Hum Retroviruses 1996, 12(16):1543-1549. 8911580
16. Li Y Kappes JC Conway JA Price RW Shaw GM Hahn BH Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes J Virol 1991, 65(8):3973-3985. 248827 1830110
17. Perelson AS Neumann AU Markowitz M Leonard JM Ho DD HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time Science 1996, 271(5255):1582-1586. 10.1126/ science.271.5255.1582 8599114
18. Michael NL Chang G Ehrenberg PK Vahey MT Redfield RR HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences J Acquir Immune Defic Syndr 1993, 6(10):1073-1085. 8105071
19. Logsdon BC VJF Martin P, Proteasa G, Koepke JI, Terlecky SR, Wawrzak Z, Winters MA, Merigan TC, Kovari LC. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity. J Virol 2004, 78(6):3123-3132. 354404 14990731 10.1128/JVI.78.6.3123-3132.2004
20. Ramratnam B MJE Zhang L, Boden D, Hurley A, Fang F, Macken CA, Perelson AS, Markowitz M, Ho DD. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 2000, 6:82-85. 10.1038/71577 10613829
21. Palmer S Maldarelli F Wiegand A Bernstein B Hanna GJ Brun SC Kempf DJ Mellors JW Coffin JM King MS Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy Proc Natl Acad Sci U S A 2008, 105(10):3879-3884. 2268833 18332425 10.1073/ pnas.0800050105